These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37560749)

  • 21. Oral Sodium Bicarbonate Supplementation Does Not Affect Serum Calcification Propensity in Patients with Chronic Kidney Disease and Chronic Metabolic Acidosis.
    Aigner C; Cejka D; Sliber C; Fraunschiel M; Sunder-Plassmann G; Gaggl M
    Kidney Blood Press Res; 2019; 44(2):188-199. PubMed ID: 31067546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dietary control of metabolic acidosis in chronic kidney disease].
    Laboux T; Azar R
    Nephrol Ther; 2019 Dec; 15(7):491-497. PubMed ID: 31056406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preservation of kidney function in kidney transplant recipients by alkali therapy (Preserve-Transplant Study): rationale and study protocol.
    Wiegand A; Ritter A; Graf N; Arampatzis S; Sidler D; Hadaya K; Müller TF; Wagner CA; Wüthrich RP; Mohebbi N
    BMC Nephrol; 2018 Jul; 19(1):177. PubMed ID: 30001705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial.
    BiCARB study group
    BMC Med; 2020 Apr; 18(1):91. PubMed ID: 32268897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis.
    Mathur VS; Bushinsky DA; Inker L; Klaerner G; Li E; Parsell D; Perkovic V; Stasiv Y; Walker M; Wesson DE; Wheeler DC; Tangri N
    Nephrol Dial Transplant; 2023 May; 38(6):1448-1458. PubMed ID: 36331426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Fruit and Veggies for Kidney Health Study: A Prospective Randomized Trial.
    Kitzman H; Montgomery AH; Khan M; Mamun A; Tecson KM; Allison P; Simoni J; Wesson DE
    Kidney Med; 2023 Dec; 5(12):100736. PubMed ID: 38046912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evidence that treatment of metabolic acidosis slows the progression of chronic kidney disease.
    Goraya N; Wesson DE
    Curr Opin Nephrol Hypertens; 2019 May; 28(3):267-277. PubMed ID: 30681417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
    Wesson DE; Mathur V; Tangri N; Stasiv Y; Parsell D; Li E; Klaerner G; Bushinsky DA
    Lancet; 2019 Apr; 393(10179):1417-1427. PubMed ID: 30857647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial.
    Dubey AK; Sahoo J; Vairappan B; Haridasan S; Parameswaran S; Priyamvada PS
    Nephrol Dial Transplant; 2020 Jan; 35(1):121-129. PubMed ID: 30053298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrating Risk-Based Care for Patients With Chronic Kidney Disease in the Community: Study Protocol for a Cluster Randomized Trial.
    Harasemiw O; Drummond N; Singer A; Bello A; Komenda P; Rigatto C; Lerner J; Sparkes D; Ferguson TW; Tangri N
    Can J Kidney Health Dis; 2019; 6():2054358119841611. PubMed ID: 31191908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Oral Sodium Bicarbonate Treatment on 24-Hour Ambulatory Blood Pressure Measurements in Patients With Chronic Kidney Disease and Metabolic Acidosis.
    Gaggl M; Repitz A; Riesenhuber S; Aigner C; Sliber C; Fraunschiel M; Cejka D; Sunder-Plassmann G
    Front Med (Lausanne); 2021; 8():711034. PubMed ID: 34552945
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolic Acidosis and Adverse Outcomes and Costs in CKD: An Observational Cohort Study.
    Reaven NL; Funk SE; Mathur V; Tangri N
    Kidney Med; 2023 May; 5(5):100622. PubMed ID: 37139081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correction of metabolic acidosis improves insulin resistance in chronic kidney disease.
    Bellasi A; Di Micco L; Santoro D; Marzocco S; De Simone E; Cozzolino M; Di Lullo L; Guastaferro P; Di Iorio B;
    BMC Nephrol; 2016 Oct; 17(1):158. PubMed ID: 27770799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence, Risk Factors, and Management of Metabolic Acidosis in Chronic Kidney Disease Patients: A Multicenter Retrospective Study in Malaysia.
    Chan JYM; Islahudin F; Mohd Tahir NA; Makmor-Bakry M; Tan CHH
    Cureus; 2024 Mar; 16(3):e56314. PubMed ID: 38628987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance to Sodium in Patients With CKD-Induced Metabolic Acidosis: Does the Accompanying Anion Matter?
    Bushinsky DA
    Am J Kidney Dis; 2019 Jun; 73(6):858-865. PubMed ID: 30518477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.
    Bushinsky DA; Hostetter T; Klaerner G; Stasiv Y; Lockey C; McNulty S; Lee A; Parsell D; Mathur V; Li E; Buysse J; Alpern R
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):26-35. PubMed ID: 29102959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Treatment of Metabolic Acidosis on Vascular Endothelial Function in Patients with CKD: A Pilot Randomized Cross-Over Study.
    Kendrick J; Shah P; Andrews E; You Z; Nowak K; Pasch A; Chonchol M
    Clin J Am Soc Nephrol; 2018 Oct; 13(10):1463-1470. PubMed ID: 30237219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary management of chronic kidney disease: protein restriction and beyond.
    Goraya N; Wesson DE
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):635-40. PubMed ID: 23079747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.